Folate bioavailability and health

Phytochemistry Reviews

Volumn 1, Issue 2, 2002, Pages 189-198

  Finglas, Paul M ^a   Wright, Anthony J A ^a  

^a INSTITUTE OF FOOD RESEARCH   (United Kingdom)

Author keywords

Absorption; Bioavailability; Disease; Folic acid; Gene; Genetics; Health; Metabolism; Polymorphism; Status

Indexed keywords

FOLIC ACID; PTEROPTIN;

CONFERENCE PAPER; DIETARY INTAKE; DNA POLYMORPHISM; DNA REPAIR; DNA SYNTHESIS; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG CONJUGATION; DRUG METABOLISM; FOOD COMPOSITION; HEALTH STATUS; HUMAN; LONGEVITY; METHYLATION; NONHUMAN; PHARMACOGENETICS; PRIORITY JOURNAL;

EID: 26244463954     PISSN: 15687767     EISSN: 1572980X     Source Type: Journal    
DOI: 10.1023/A:1022559417212     Document Type: Conference Paper

References (81)

1. Alfthan G, Aro A & Gey KF (1997) Plasma homocysteine and cardiovascular disease mortality. Lancet 349: 397.
2. Babu S & Srikantia SG (1976) Availability of folates from some foods. Am. J. Clin. Nutrit. 29: 376-379.
3. Bagley PJ & Selhub J (1998) A common mutation in the methylenetetrahydrofolate reductase gene is associated with an accumulation of formylated tetrahydrofolates in red blood cells. Proc. Nat. Acad. Sci. USA 95: 13217-13220.
4. Bailey LB, Cerda JJ, Bloch BS, Busby MJ, Vargas L, Chandler CJ & Halsted CH (1984) Effects of age on poly- and monoglutamyl folacin absorption in human subjects. J. Nutrit. 114: 1770-1776.
5. Blakley RL (1969) The Biochemistry of folic acid and related pteridines. In: Neuberger A & Tatum EL (eds) Frontiers of Biology, vol. 13 (pp. 63-105) North-Holland, London.
6. Blount BC, Mack MM, Wehr CM, MacGregor JT, Hiatt RA, Wang G, Wickramasinghe SN, Everson RB & Ames BN (1997) Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc. Nat. Acad. Sci. USA 94: 3290-3295.
7. Botiglieri T (1996) Folate, vitamin B12, and neuropsychiatric disorders. Nutrit. Rev. 54: 382-390.
8. Boushey CJ, Beresford SAA, Omenn GS & Motulsky AG (1995) A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. JAMA 274: 1049-1057.
9. Bower C, Stanley FJ, Croft M, De Clerk NH, Davis RE & Nicol DJ (1993) Absorption of pteroylpolyglutamates in mothers of infants with neural tube defects. Brit. J. Nutrit. 69: 827-834.
10. Brattstrom L & Wilcken DEL (2000) Homocysteine and cardiovascular risk: cause or effect? Am. J. Clin. Nutrit. 72: 315-323.
11. Brattstrom L, Zhang Y, Hurtig M, Refsum H, Ostensson S, Fransson L, Jones K, Landgren F, Brudin L & Ueland PM (1999) A common methylenetetrahydrofolate reductase gene mutation and longevity. Atherosclerosis 146: 395-397.
12. Brown JP, Scott JM, Foster FG & Weir DG (1973) Ingestion and absorption of naturally occurring pteroylmonoglutamates (folates) in man. Gastroenterology 64: 223-232.
13. Butterworth CE, Newman AJ & Krumdieck CL (1974) Tropical sprue: a consideration of possible etiologic mechanism with emphasis on pteroyl polyglutamate metabolism. Transact. Am. Clin. Climatol. Asso. 86, 11-22.
14. Choi SW & Mason JB (2000) Folate and carcinogenesis: An integrated scheme. J. Nutrit. 130: 129-132.
15. Cristensen B, Arbour L, Tran P, Leclerk D, Sabbaghian N, Platt R, Gilfix BM, Rosenblatt DS, Gravel RA, Forbes P & Rozen R (1999) Genetic polymorphisms in methylenetetrahydrofolate reductase and methionine synthase, folate levels in red blood cells, and risk of neural tube defects. Am. J. Med. Genet. 84: 151-157.
16. Daly LE, Kirke PN, Molloy A, Weir DG & Scott JM (1995) Folate levels and neural tube defects. Implications for prevention. JAMA 274: 1698-1702.
17. Department of Health (1991) Report on Health and Social subjects. 41. Dietary Reference Values for Food Energy and Nutrients for the United Kingdom. Her Majesty's Stationery Office, London.
18. Department of Health (2000) Report on Health and social subjects. 50. Folic acid and the Prevention of Disease. Report of the Committee on Medical Aspects of Food and Nutrition Policy. The Stationery Office, London.
19. Devlin AM, Ling E-H, Peerson JM, Fernando S, Clarke R, Smith DA & Halsted CH (2000) Glutamate carboxypeptidase II: A polymorphism associated with lower levels of serum folate and hyperhomocysteinemia. Hum. Mol. Genet. 9: 2837-2844.
20. Ericson A, Kallen B & Aberg A (2001) Use of multivitamins and folic acid in early pregnancy and multiple births in Sweden. Twin Res. 4: 63-66.
21. Fenech M, Noakes N, Clifton P & Topping D. (1999) Aleurone flour is a rich source of bioavailable folate in humans. J. Nutrit. 129: 1114-1119.
22. Finglas PM, Witthöft CM, Vahteristo L, Wright AJA, Southon S, Mellon F, Ridge B & Maunder P (2002) Use of an oral/intravenous dual-label stable-isotope protocol to determine folic acid bioavailability from fortified cereal grain foods in women. J. Nutr. 132, 936-939.
23. Ford JE, Salter DN & Scott KJ (1969) The folate-binding protein in milk. J. Dairy Res. 36: 435-446.
24. Friso S, Choi SW, Girelli D, Mason JB, Dolnikowski GG, Bagley PJ, Oliveri O, Jaques PF, Rosenburg IH, Corrocher R & Selhub J (2002) A common mutation in the 5,10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status. Proc. Nat. Acad. Sci. USA 99: 5606-5611.
25. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJH, den Heijer M, Kluijtmans LAJ van den Heuvel LP & Rozen R (1995) A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase. Nature Genet. 10: 111-113.
26. Gaughan DJ, Kluijtmans LAJ, Barbaux S, McMaster D, Young IS, Yarnell JWG, Evans A & Whitehead AS (2001) The methionine synthase reductase (MTRR) A66G polymorphism is a novel genetic determinant of plasma homocysteine concentrations. Atherosclerosis 157: 451-456.
27. Ghitis J (1967) The folate binding in milk. Am. J. Clin. Nutrit. 20: 1-4.
28. Gregory JF III (1997) Bioavailability of folate. Europ. J. Clin. Nutrit. 51:S54-S59.
29. Gregory JF III (2001) Case study: Folate bioavailability. J. Nutrit. 131: 1376S-1382S.
30. Gregory JF & Toth JP (1988) Chemical synthesis of deuterated folate monoglutamate and in vivo assessment of urinary excretion of deuterated folates in man. Analyt. Biochem. 170: 94-104.
31. Halsted CH (1979) The intestinal absorption of folates. Am. J. Clin. Nutrit. 32: 846-855.
32. Halsted CM (1980) Intestinal absorption and malabsorption of folates. Ann. Rev. Med. 31: 79-87.
33. Hart DJ, Finglas PM, Wolfe CA, Mellon F, Wright AJA & Southon S (2002) Determination of 5-methyltetrahydrofolate (13C-labelled and unlabelled) in human plasma and urine by combined liquid chromatography mass spectrometry (LC/MS). Analyt. Biochem. 305: 206-213.
34. Hasbargen U, Lohse P & Thaler CJ (2000) The number of dichorionic twin pregnancies is reduced by the common MTHFR 677 C→T mutation. Hum. Reprod. 15: 2659-2662.
35. Heijmans BT, Gussekloo J, Kluft C, Droog S, Lagaay AM, Knook DL, Westendorp RG & Slagboom EP (1999) Mortality risk in men is associated with a common mutation in the methylenetetrahydrofolate reductase gene (MTHFR). Europ. J. Hum. Genet. 7: 197-204.
36. th ed. (pp. 402-425). Lea & Febiger, Philadelphia.
37. Hobbs CA, Sherman SL, Yi P, Hopkins SE, Torfs CP, Hine RJ, Pogribna M, Rozen R & James SJ (2000) Polymorphisms in genes involved in folate metabolism as maternal risk factors for Down syndrome. Am. J. Hum. Genet. 67: 623-630.
38. Hoppner K & Lampi B (1980) Folate levels in human liver autopsies in Canada. Am. J. Clin. Nutrit. 33: 862-864.
39. Institute of Medicine (2000). Dietary reference intakes for thiamine, riboflavin, niacin, vitamin B6, folate, vitamin B12, pantothenic acid, biotin and choline. A report of the Standing Committee on the Scientific Evaluation of Dietary Reference Intakes and its Panel on Folate, Other B Vitamins, and Choline and Subcommittee on Upper Reference Levels of Nutrients, Food and Nutrition Board, Institute of Medicine. National Academy Press, Washington DC.
40. James SJ, Pogribna M, Porgribny IP, Melnyk S, Hine RJ, Gibson JB, Yi P, Tafoya DL, Swenson DH, Wilson VL & Gaylor DW (1999) Abnormal folate metabolism and mutation in the methylenetetrahydrofolate reductase gene may be maternal risk factors for Down syndrome. Am. J. Clin. Nutrit. 70: 495-501.
41. Kang SS, Wong PW, Susmano A, Sora J, Norusis M & Ruggie N (1991) Thermolabile methylenetetrahydrofolate reductase: an inherited risk factor for coronary artery disease. Am. J. Hum. Genet. 48: 536-545.
42. Kang SS, Wong PWK & Malinow MR (1992) Hyperhomocysteinemia as a risk factor for occlusive vascular disease. Ann. Rev. Nutrit. 12: 279-298.
43. Kelly P, McPartlin J, Goggins M, Weir DG & Scott JM (1997) Unmetabolised folic acid in serum: acute studies in subjects consuming fortified food and supplements. Am. J. Clin. Nutrit. 65: 1790-1795.
44. Li H, Lewis A, Brodsky S, Reiger R, Iden C & Gologorsky MS (2002) Homocysteine induses 3-hydroxy-3-methylglutaryl coenzyme A reductase in vascular endothelial cells: A mechanism for development of atherosclerosis? Circulation 105: 1037-1043.
45. Lucock MD, Wild J, Smithells RW & Hartley R (1989) In vivo characterization of the absorption and biotransformation of pteroylmonoglutamic acid in man: A model for future studies. Biochem. Med. Metabol. Biol. 42: 30-42.
46. Martinelli M, Scapoli L, Pezzetti F, Carinci F, Carinci P, Stabellini G, Bisceglia L, Gombos F & Tognon M (2001) C677Tvariant form at the MTHFR gene and CL/P: a risk factor for mothers? Am. J. Med. Genet. 98: 357-360.
47. Mills JL, Kirke PN, Molloy AM, Burke H, Conley MR, Lee YJ, Mayne PD, Weir DG & Scott JM (1999) Methylenetetrahydrofolate reductase thermolabile variant and oral clefts. Am. J. Med. Genet. 86: 71-74.
48. Mitchell HK, Snell EE & Williams RJ (1941) The concentration of 'folic acid'. J. Am. Chem. Soc. 63: 2284.
49. Molloy AM, Mills JL, Kirke PN, Whitehead AS, Weir DG & Scott JM (1998) Whole-blood folate values in subjects with different methylenetetrahydrofolate reductase genotypes: Differences between the radioassay and microbiological assays. Clin. Chem. 44: 186-188.
50. Munoz-Moran E, Dieguez-Lucena JL, Fernandez-Arcas N, Peran-Mesa S & Reyes-Engel A (1998) Genetic selection and folate intake during pregnancy. Lancet 352: 1120-1121.
51. Ou CY, Stevenson RE, Brown VK, Schwartz CE, Allen WP, Khoury MJ, Rozen R, Oakley GP & Adams MJ Jr (1996) 5,10 methylenetetrahydrofolate reductase genetic polymorphism as a risk factor for neural tube defects. Am. J. Med. Genet. 63: 610-614.
52. Perry J & Chanarin I (1970) Intestinal absorption of reduced folate compounds in man. Brit. J. Haematol. 18: 329-339.
53. Perry J & Chanarin I (1972) Observations on folate absorption with particular reference to folate polyglutamate and possible inhibitors to its absorption. Gut 13: 544-550.
54. Pfeiffer CM, Rogers LM, Bailey LB & Gregory JF (1997) Absorption of folate from fortified cereal-grain products and of supplemental folate consumed with or without food determined by using a dual-label stable isotope protocol. Am. J. Clin. Nutrit. 66: 1388-1397.
55. Pietrzik K, Hages M & Remer T (1990) Methodological aspects in vitamin bioavailability testing. J. Micronutr. Analys. 7: 207-222.
56. Prinz-Langenohl R, Bronstrup A, Thorand B, Hages M & Pietrzik K (1999) Availability of food folate in humans. J. Nutrit. 129: 913-916.
57. Quere I, Perneger TV, Zittoun J, Bellet H, Gris J-C, Daures J-P, Schved J-F, Mercier E, Laroche J-P, Dauzat M, Bounameaux H, Janbon C & de Moerloose P (2002) Red blood cell methyfolate and plasma homocysteine as risk factors for venous thromboembolism: A matched case-control study. Lancet 359: 747-752.
58. Quinlivan EP, McPartlin J, McNulty H, Ward M, Strain JJ, Weir DG & Scott JM (2002) Importance of both folic acid and vitamin B12 in reduction of risk of vascular disease. Lancet 359: 227-228.
59. Rabinowitz JC (1960) Folic acid. In: Boyer PD, Lardy H & Myrback (eds) The Enzymes, Vol 2. (pp. 185-252). Academic Press, New York.
60. Rady PL, Szucs S, Grady J, Hudnall SD, Kellner LH, Nitowsky H, Tyring SK & Matalon RK (2002) Genetic polymorphisms of methylenetetrahydrofolate reductase (MTHFR) and methionine synthase reductase (MTRR) in ethnic populations in Texas; a report of a novel MTHFR polymorphic site, G1793A. Am. J. Med. Genet. 107: 162-168.
61. Reisenauer AM, Krumdieck CL & Halsted CH (1977) Folate conjugase: Two separate activities in human jejunum. Science 198: 196-197.
62. 2] folic acid. J. Nutrit. 127: 2321-2327.
63. Russell RM, Dahr GJ, Dutta SK & Rosenburg IH (1979) Influence of intraluminal pH on folate absorption. Studies in control subjects and in patients with pancreatic insufficiency. J. Lab. Clin. Med. 93: 428-436.
64. Ryan BM & Weir DG (2001) Relevance of folate metabolism in the pathogenesis of colorectal cancer. J. Lab. Clin. Med. 138: 164-176.
65. Salter DN & Blakeborough P (1988) Influence of goat's milk folate-binding protein on transport of 5-methyltetrahydrofolate in neonatal goat small intestinal brush border membrane vesicles. Brit. J. Nutrit. 59, 497-507.
66. Schneider JA, Rees DC, Liu Y-T & Clegg JB (1998) Worldwide distribution of a common methylenetetrahydrofolate reductase mutation. Am. J. Hum. Genet. 62: 1258-1260.
67. Scott JM (1999) Folate and vitamin B-12. Proc. Nutrit. Soc. 58: 441-448.
68. Scott JM (2000) Homocysteine and cardiovascular risk. Am. J. Clin. Nutrit. 72: 333-334.
69. Selhub J, Powell GM & Rosenburg IH (1984). Intestinal transport of 5-methyltetrahydrofolate. Am. J. Physiol. 246: G515-G520.
70. Silaste M-L, Rantala M, Sampi M, Alfthan G, Aro A & Kesaniemi A (2001) Polymorphisms of key enzymes in homocysteine metabolism affect diet responsiveness of plasma homocysteine in health women. J. Nutrit. 131: 2643-2647.
71. Steinberg SE, Campbell CL & Hillman RS (1979) Kinetics of the normal folate enterohepatic cycle. J. Clin. Investig. 64: 83-88.
72. Tamura T & Stokstad ELR (1973) The availability of food folate in man. Brit. J. Haematol. 25: 513-532.
73. Ueland PM, Refsum H, Beresford SAA & Vollset SE (2000) The controversy over homocysteine and cardiovascular risk. Am. J. Clin. Nutrit. 72: 324-332.
74. Vollset SE, Refsum H, Tverdal A, Nygard O, Nordrehaug JE, Tell GS & Ueland PM (2001) Plasma total homocysteine and cardiovascular and noncardiovascular mortality: The Hordaland homocysteine study. Am. J. Clin. Nutrit. 74: 130-136.
75. Wagner C (1985) Folate-binding proteins. Nutrit. Rev. 43: 293-299.
76. Wagner C (1996) Symposium on the subcellular compartmentation of folate metabolism. J. Nutrit. 126: 1228S-1234S.
77. Weir DG, McGing PG & Scott JM (1985) Commentary: Folate metabolism, the enterohepatic circulation and alcohol. Biochem. Pharmacol. 34: 1-7.
78. 27 carriers. Clin. Cancer Res. 7: 3416-3422.
79. Whitehead VM (1973) Polygammaglutamyl metabolites of folic acid in humans liver. Lancet 1: 743-745.
80. Wills L (1931) Treatment of 'pernicious anaemia of pregnancy' and 'tropical anaemia' with special reference to yeast extract as a curative agent. Brit. Med. J. 1: 1059-1064.
81. Wilson A, Platt R, Wu Q, Leclerc D, Christensen B, Yang H, Gravel RA & Rozen R (1999) A common variant in methionine synthase reductase combined with low cobalamin (vitamin B-12) increases risk for spina bifida. Mol. Genet. Metabol. 67: 317-323.